GamEvac-Combi (Russian: ГамЭвак-Комби) is a heterologous VSV- and Ad5-vectored Ebola vaccine. There is also a version called GamEvac which is a homologous Ad5-vectored vaccine. GamEvac-Combi was developed by Gamaleya Research Institute of Epidemiology and Microbiology. As of 2015 the vaccine has been licensed in Russia for emergency use, on the basis of Phase 1 and Phase 2 clinical trials.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - GamEvac-Combi (en)
- GamEvac-Combi (in)
- ГамЭвак-Комби (ru)
|
rdfs:comment
| - GamEvac-Combi (Russian: ГамЭвак-Комби) is a heterologous VSV- and Ad5-vectored Ebola vaccine. There is also a version called GamEvac which is a homologous Ad5-vectored vaccine. GamEvac-Combi was developed by Gamaleya Research Institute of Epidemiology and Microbiology. As of 2015 the vaccine has been licensed in Russia for emergency use, on the basis of Phase 1 and Phase 2 clinical trials. (en)
- GamEvac-Combi (bahasa Rusia: ГамЭвак-Комби) adalah sebuah . Vaksin tersebut juga disebut sebagai GamEvac. GamEvac-Combi dikembangkan oleh Institut Riset Epidemiologi dan Mikrobiologi Gamaleya. Hingga 2015 vaksin tersebut dilisensikan di Rusia untuk pemakaian darurat, atas dasar pengujian klinis Tahap 1 dan Tahap 2. (in)
- «ГамЭвак-Комби» — российская комбинированная векторная вакцина для профилактики геморрагической лихорадки Эбола. Разработана Национальным исследовательским центром эпидемиологии и микробиологии имени Н. Ф. Гамалеи. Условия соблюдения холодовой цепи вакцины — −20 °С, для лиофилизированной формы — +4 °С. (ru)
|
foaf:name
| |
dct:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
vaccine type
| |
dbp:wikiPageUsesTemplate
| |
drug name
| |
legal status
| |
target
| |
type
| |
has abstract
| - GamEvac-Combi (Russian: ГамЭвак-Комби) is a heterologous VSV- and Ad5-vectored Ebola vaccine. There is also a version called GamEvac which is a homologous Ad5-vectored vaccine. GamEvac-Combi was developed by Gamaleya Research Institute of Epidemiology and Microbiology. As of 2015 the vaccine has been licensed in Russia for emergency use, on the basis of Phase 1 and Phase 2 clinical trials. (en)
- GamEvac-Combi (bahasa Rusia: ГамЭвак-Комби) adalah sebuah . Vaksin tersebut juga disebut sebagai GamEvac. GamEvac-Combi dikembangkan oleh Institut Riset Epidemiologi dan Mikrobiologi Gamaleya. Hingga 2015 vaksin tersebut dilisensikan di Rusia untuk pemakaian darurat, atas dasar pengujian klinis Tahap 1 dan Tahap 2. (in)
- «ГамЭвак-Комби» — российская комбинированная векторная вакцина для профилактики геморрагической лихорадки Эбола. Разработана Национальным исследовательским центром эпидемиологии и микробиологии имени Н. Ф. Гамалеи. Условия соблюдения холодовой цепи вакцины — −20 °С, для лиофилизированной формы — +4 °С. (ru)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |